Tata Chemicals working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
323.27×323.27×322.26×341.62×268.25×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
49.90×49.90×46.58×53.57×49.57×
290.14×290.14×309.39×335.54×288.73×
83.03×83.03×59.45×59.65×29.09×
32.87×31.70×25.62×50.89×5.16×
0.38×0.38×0.40×0.43×0.49×
−0.74×−0.74×4.55×6.93×1.22×
0.70×0.70×0.90×1.06×0.78×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

TATACHEM₹603.45

Tata Chemicals Ltd.

· Chemicals
₹ CrorePeersGHCLAARTIINDJGCHEMCHAMBLFERTNAVINFLUORDEEPAKFERTHSCLNOCILMcap ₹15,388 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)268.25341.62322.26323.27323.27
Receivable Days (DSO)49.5753.5746.5849.9049.90
Payable Days (DPO)288.73335.54309.39290.14290.14
Cash Conversion Cycle (days)29.0959.6559.4583.0383.03
Working Capital Turnover5.1650.8925.6231.7032.87
Asset Turnover0.490.430.400.380.38
Cash Conversion (CFO/Net Income)1.226.934.55-0.74-0.74
CFO/EBITDA0.781.060.900.700.70
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.